We are live on ! Find out more
SIA

Sit Investment Associates Portfolio holdings

AUM $4.93B
1-Year Est. Return 12.22%
This Fund
S&P 500
This Quarter Est. Return
-1.03%
1 Year Est. Return
+12.22%
3 Year Est. Return
+41.16%
5 Year Est. Return
+31.78%
10 Year Est. Return
+136.16%
AUM
$5.46B
AUM Growth
-$310M
Cap. Flow
-$240M
Cap. Flow %
-4.39%
Top 10 Hldgs %
17.87%
Holding
522
New
96
Increased
123
Reduced
173
Closed
37

Top Buys

Rank Stock Value
1
TGT icon
Target
TGT
+$46.9M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$27.2M
3
V icon
Visa
V
+$22.8M
4
DAL icon
Delta Air Lines
DAL
+$21.2M
5
BRX icon
Brixmor Property Group
BRX
+$20.4M

Top Sells

Rank Stock Value
1
DRA
Diversified Real Asset Income Fd
DRA
+$26.4M
2
ZBH icon
Zimmer Biomet
ZBH
+$22.5M
3
STJ
St Jude Medical
STJ
+$22M
4
JNJ icon
Johnson & Johnson
JNJ
+$19.8M
5
HP icon
Helmerich & Payne
HP
+$19.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.31%
2 Technology 12.08%
3 Industrials 11.14%
4 Financials 9.57%
5 Consumer Discretionary 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EME icon
251
Emcor
EME
$36B
$1.81M 0.03%
37,925
-1,700
-4% -$79.2K
BCRX icon
252
BioCryst Pharmaceuticals
BCRX
$2.4B
$1.8M 0.03%
120,675
– –
TPC
253
Tutor Perini Cor
TPC
$5.21B
$1.8M 0.03%
83,320
-1,200
-1% -$27.4K
ABCO
254
DELISTED
Advisory Board Co
ABCO
$1.79M 0.03%
32,800
-700
-2% -$36.1K
DBI icon
255
Designer Brands
DBI
$333M
$1.78M 0.03%
+53,325
New +$1.9M
WFC icon
256
Wells Fargo
WFC
$264B
$1.77M 0.03%
31,425
+850
+3% +$47.4K
AMCX icon
257
AMC Global Media
AMCX
$489M
$1.75M 0.03%
21,400
– –
FFIV icon
258
F5
FFIV
$22.7B
$1.71M 0.03%
14,225
-5,275
-27% -$649K
DST
259
DELISTED
DST Systems Inc.
DST
$1.71M 0.03%
27,180
+1,280
+5% +$75.9K
JAZZ icon
260
Jazz Pharmaceuticals
JAZZ
$16.7B
$1.69M 0.03%
9,600
– –
NQI
261
DELISTED
NUVEEN QUALITY MUNICIPAL FUND INC
NQI
$1.66M 0.03%
131,856
-25,742
-16% -$335K
VRTX icon
262
Vertex Pharmaceuticals
VRTX
$126B
$1.64M 0.03%
13,300
– –
RCS
263
PIMCO Strategic Income Fund
RCS
$250M
$1.64M 0.03%
+188,358
New +$1.71M
TW
264
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
$1.64M 0.03%
13,000
– –
WAB icon
265
Wabtec
WAB
$49.3B
$1.63M 0.03%
17,275
-300
-2% -$29.5K
AMN icon
266
AMN Healthcare
AMN
$1.4B
$1.61M 0.03%
51,125
– –
CSL icon
267
Carlisle Companies
CSL
$15.4B
$1.61M 0.03%
16,135
+835
+5% +$81.9K
WNR
268
DELISTED
Western Refining Inc
WNR
$1.61M 0.03%
36,950
+1,450
+4% +$64.4K
CLDX icon
269
Celldex Therapeutics
CLDX
$3.28B
$1.6M 0.03%
4,218
– –
SCOR icon
270
Comscore
SCOR
$109M
$1.59M 0.03%
1,498
– –
FMC icon
271
FMC
FMC
$1.33B
$1.55M 0.03%
34,129
– –
KNGT
272
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
$1.55M 0.03%
57,900
+1,150
+2% +$30.7K
RVTY icon
273
Revvity
RVTY
$12.8B
$1.52M 0.03%
28,825
+1,300
+5% +$67.8K
PTY icon
274
PIMCO Corporate & Income Opportunity Fund
PTY
$2.51B
$1.51M 0.03%
+104,372
New +$1.59M
SNCR
275
DELISTED
Synchronoss Technologies
SNCR
$1.51M 0.03%
+3,669
New +$1.58M
9 10
11
12 13

Similar funds

MCM
Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
FC
Freemont Capital Singapore $4.91B AUM 5.45% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Sit Investment Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Sit Investment Associates held 522 positions worth $5.46B, down 5.4% from $5.77B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Sit Investment Associates withdrew a net $240M in Q2 2015, closing 37 positions and reducing 173 holdings. Its most notable exit was Cummins, an estimated $19.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.

Against the trend, Sit Investment Associates opened a new position in Teva Pharmaceuticals worth $26.1M.

  • Sit Investment Associates's largest Q2 2015 buy was Teva Pharmaceuticals: 441,660 shares worth $26.1M.
  • Sit Investment Associates added most to Target in Q2 2015, an estimated $46.9M increase.
  • Sit Investment Associates's biggest Q2 2015 reduction was Diversified Real Asset Income Fd, cutting an estimated $26.4M.
  • Sit Investment Associates fully exited Cummins in Q2 2015, selling an estimated $19.5M.
  • Sit Investment Associates's ten largest holdings make up 18% of its $5.46B portfolio in Q2 2015.
  • Sit Investment Associates opened 96 new positions and closed 37 in Q2 2015.
  • Sit Investment Associates's portfolio value fell 5.4% quarter-over-quarter to $5.46B.

Based on Sit Investment Associates's 13F filing for Q2 2015, filed 20 Jul 2015.